ABSTRACT: Clearance of a n aroA delet~on mutant of Aerornonas salmonjcida from tissues of rainbow trout Oncorhynchus rnykiss was studied under a number of conditions. Following intraperitoneal injection into trout, the bacteria were rapidly found in all tissues/body fluids examined (kidney, spleen, liver, heart, muscle, blood and peritoneal fluid), with highest recoveries in the spleen and peritoneal fluid. Whilst in some tissues numbers increased over the f~rst few days post-injection, in general clearance had been effected within 7 to 9 d at 16'C regardless of the ~noculum dose. However, with the highest dose (2 X 10' bacteria per fish) used some fish mortalities occurred. Temperature was shown to influence clearance, with low water temperatures significantly delaying clearance. Whole body homogenates conf~rmed that some increase in bacterial numbers occurred in vivo, after an initial and Immediate dramatic drop in bacterial v~ability. Finally, a 2 h crowding stress which significantly elevated blood glucose levels had no effect upon clearance. These results are discussed with respect to the possible use of this deletion mutant as a live vaccine in aquaculture.
INTRODUCTION
With the success of many vaccines in aquaculture has come an interest in more novel vaccines, such as recombinant subunit vaccines, peptide vaccines and live, attenuated vaccines. Each has a number of advantages over whole, killed vaccines (Brown et al. 1993) , but have yet to have a major impact in fish vaccine design. With respect to bacterial vaccines, several recent successes with prototype live vaccines (Thornton et al. 1991 , Vaughan et al. 1993 , Norqvist et al. 1994 ) have focussed attention on this particular approach. Live vaccines are known to be effective stimulators of cell-mediated immune responses, espep 'Present address: Veterinary Medicines Directorate, Woodham Lane, New Haw, Addlestone, Surrey KT15 3NB, UK "Addressee for correspondence. E-mail: c.secombes@abdn.ac.uk cially important for intracellular pathogens, and are able to elicit responses at mucosal surfaces via oral administration (Dougan et al. 1987 ). In addition, it is apparent that many novel molecules on pathogens are preferentially expressed in vivo, as with the salmonid bacterial pathogen Ael-omonas salmonic~da (Garduno et al. 1993a , b, Thornton et al. 1993 , Hirst & Ellis 1994 . Live vaccines clearly have the potential to express such molecules in vivo, including any yet to be characterised, before elimination by the host immune system. One problem associated with the use of live vaccines has been the concern over the possible reversion to virulence, through changes in the bacteria or c,ompromising conditions in the host. For example, a live vaccine may be cleared by a healthy host but may overcome a stressed or otherwise immunologically compromised host. This is a particular concern with naturally attenuated mutants, where it is often not known exactly how the attenuation has been achieved. However, ad-vances in molecular biological techniques allow the production of genetically attenuated mutants, as with the aroA deletion mutant (AaroA) of Aeromonas salmonicida developed by Vaughan et al. (1990) where an aroA::kanamycin resistance mutation was introduced into the chromosome of A. salmonicida by allele replacement uslng a suicide plasmid delivery system. No revertants were detectable among 10" bacteria examined (Vaughan et al. 1993) , and doses of up to 10' bacteria per fish, injected intramuscularly (i.m.) into brown trout Salmo trufta or Atlantic salmon Salmo salar had no adverse effect on fish health, confirming that this mutant was attenuated. In contrast, the wild type bacterium from which this strain was derived killed all salmon within 3 d of a n i.m, injection of 106 bacteria per fish. Thus, deletion of genes resulting in severe metabolic deficiency appears to be a most rational approach to attenuation.
Recently a mark I1 strain of the AaroA mutant of Aeromonas salmonicida (Brivax 11) has been developed (Marsden et al. 1996a ). This strain contains a complete deletion of the aroA gene, constructed by allele replacement, and thus lacks kanamycin resistance. The present study was carried out to investigate in detail the clearance of this strain from rainbow trout Oncorhynchus mykiss using a variety of temperature and dose regimes. Such data is essential to understand what factors may influence the ability of this strain to stimulate the fish immune system, prior to its development as a commercial vaccine.
MATERIALS AND METHODS
Fish. Rainbow trout Oncorhynchusmykiss, weighing approximately 50 g, were obtained from local fish farms and maintained in aerated f~breglass tanks supplied with a continuous flow of recirculating water at 10 to 16°C. Fish were fed twice daily on commercial trout food (EWOS). Fish vaccinated with the live Brivax bacterium were placed in the pathogen containment aquarium facility at the Department of Zoology, University of Aberdeen, where the outflow water was sterilised by contact with hypochlorite.
Bacterial passaging. Brivax I1 were inoculated from storage at -70°C into 3 % tryptic soy broth (TSB, Gibco) . Following an initial 24 h incubation of cultures at 20°C, bacteria were sub-cultured and grown for a further 24 to 48 h at this temperature prior to their use for vaccination.
Clearance of Brivax 11. Groups of 20 to 30 rainbow trout, acclimated to 10, 13 or 16"C, were anaesthetised using ethyl-4-aminobenzoate (Benzocaine, Merck) at 25 pg ml-l water. The fish were then vaccinated intraperitoneally (i.p.) with Brivax I1 at a concentration of 2 X 107, 2 X 108 or 2 X 10' bacter~a per fish. In one set of experiments, fish were given a 2 h crowding stress, according to Thompson et al. (1993) , prior to injection to study clearance in immunocompromised animals. To confirm that stress had an effect in vivo, serum samples were taken from, fish in this experiment at the time of vaccination, for determ~nation of serum glucose levels as described by Thompson et al. (1993) .
Levels of bacteria present in the tissues of vaccinated fish were assessed every other day for 7 to 12 d after vaccination, dependent on the nature of the experiment. At each sampling time 5 fish were taken and either homogenised in a co.mmercia1 blender (Jencons) containing 50 n~l 0.15 M phosphate-buffered saline pH 7.2 (PBS, Gibco), or bled and then dissected and selected tissues (kidney, spleen, liver, dorsal muscle, heart) removed for analysis and weighed. In addition, peritoneal washes were collected by flushing the peritoneal cavity with 200 p1 PBS following removal of the organs. Prior to use, the whole body homogenates and 200 p1 whole blood samples were diluted 1:10 and 1:5, respectively, in PBS. For preparation of the tissue samples, the surfaces of each tissue were initially washed with PBS to remove potentially contaminating surface bound Brivax, especially important for samples from within the peritoneal cavity. Subsequently, washed tissue samples were pushed through a nylon mesh (100 pm) with 10 m1 PBS. Five-fold dilutions of each of the prepared whole body, blood, peritoneal washes or tissue suspensions were then made and plated onto tryptic soy agar (TSA, Gibco) plates. Plates were incubated for 48 h at 2OoC, the resultant Aeromonas salmonicida colony forming units (cfu) counted and the mean number of bacteria present per fish, per 0.1 g tissue or per 200 p1 body fluid (blood and peritoneal fluid) estimated. The sensitivity of the assay was estim.ated to be 83 cfu per sample.
Data were analysed by 1-and 2-way analysis of variance (ANOVA) for the time, dose and temperature experiments, and by l-way ANOVA for the stress experiment.
RESULTS

Clearance of Brivax I1
As seen In Fig 1, following i p inlectlon of 2 :
< 108 Brlvax I1 into rainbow trout acclimated to 16OC, there was a r a p~d dlssemlnation to all tissues examlned That Brlvax I1 was found within the blood dunng the flrst few days post-injection suggests that ~t becomes syst e m~~ Highest cfu were recorded in the spleen and peritoneal fluld, sltes potentially influenced by the route of injection However, the numbers of cfu recov- ered from the heart and dorsal muscle were significant and well removed from the injection site. Whllst in some tissues highest numbers of cfu were found on Day l (kidney, liver, heart), this was not always the case and numbers also peaked on Day 3 (spleen, muscle) or Day 5 (peritoneal fluid). Nevertheless, in all cases numbers had dramatically fallen by Day 7 ( p 0.001 relat~ve to values present at Day l ) , and were only detectable in the peritoneal fluid. At Day 9 no cfu were detected in any samples In this experiment. In a separate experiment performed using the same conditions as above, the percentage of fish with infected tissues was calculated. As seen in Fig. 2 , on Day 1 post-injection all tissues were infected in all fish. However, by Day 3, 1 fish had cleared the infection in the muscle, kidney and heart, and 2 others had cleared the Brivax I1 from a single tissue (heart or kidney). By Day 5, again 1 fish had cleared the infection from all tissues examined, and all the others had cleared 1 01-more tissues. Finally, at Day 7 all fish had cleared the heart, but low numbers of bacteria were still present in several tissues of some fish, which had not entirely cleared the infection at this time despite recoveries of Brivax over the first few days essentially similar to those seen in the previous experiment.
Since the numbers of bacteria present in some tissues had increased with time, a further experiment was performed to investigate what was happening at the whole animal level. Following injection, fish were homogenised and the numbers of cfu per fish calculated. It was clear that within minutes (the time taken to inject and then homogenise the fish, etc.) there was a dramatic reduction in cfu to around 24 O/o of the starting inoculum (Fig. 3 ) . This value decreased a little fur- 
Effect of dose on clearance
To examine the effect of inoculum dose on tissue persistence, 3 groups of trout were injected with 2 X 107, 2 X 108 or 2 X 10' bacteria at 16°C. As seen in Flg. 4, fish injected with 2 X lo7 bacteria rapidly cleared the ~n f e ction from the kidney, and by Day 3 no bacteria were detectable. As previously, highest numbel-S of cfu were found in the kidney on Day 1 using 2 X 108 bacteria per fish, with significantly lower (p i 0.01) numbers present on Days 3 and 5 , and none belng detectable by 
Effect of temperature on clearance
To examine the effect of temperature on tissue persistence, 3 groups of trout were acclimated to 10, 13 or 16°C and injected with 2 X 108 bacteria per fish. As seen in Fig. 5 , fish injected at 16'C showed s~milar results to those above, in that bacteria were detectable in the kidney (Fig 5a), liver (Fig. 5b) and spleen (Fig. 5c ) during the first week post-injection but were cleared, in general, by Day 9. At 13"C, bacteria persisted for longer than at 16OC in the liver and spleen, and were still detectable, although at low levels, at Day 12, the last time examined. Bacterial numbers were also significantly higher ( p < 0.01) overall than in tissues from fish kept at 16OC, indicating a faster clearance rate in the latter. At 10°C, whilst bacterial numbers significantly decreased (p < 0.01) with time in all tissues examined, the rate of clearance was much reduced relative to the other 2 temperatures and bacteria were still detectable at relatively high numbers on Day 12. Effect of stress on clearance Following a 2 h crowding stress, previously shown to dramatically compromise head kidney leucocyte bacteric~dal and respiratory burst activity (Thompson et al. 1993) , no impact on clearance rate was detectable relative to control fish, following injection with 2 X 108 bacter~a per fish at 16°C (Fig. 6) . At both Days 1 and 3 post-injection, there were no significant differences in the numbers of bacteria recovered in either the kidney or spleen of control and stressed fish. That the 2 h stress did indeed elicit an effect was assessed by monitoring glucose levels in serum samples taken from the 2 groups at the time of vaccination. Stressed fish had significantly higher (p < 0.05) serum glucose levels (163.9 +-13.1 rng dl-l) compared with control fish (97.9 + 7.7 mg dl-l). present study may have resulted from hlgh levels of proteases/tox~ns (Pnce et a1 1989, Lee & Ellis 1990, Ellis in press) released from the bacteria prior to clearance, with the relatively small fish used in the present study being more susceptible than larger fish at this dose (authors' pers obs ) However, a dose of 2 X 1 0 ' bacteria pei fish is some 40 times higher than the dose of Brivax 
DISCUSSION
Analysis of the clearance of a genetically attenuated (AaroA) strain of Aeromonas salmonicida (Brivax 11) from rainbow trout tissues and body fluids revealed that post-injection the bacteria were rapidly found in all tissues examined, and were typically cleared within a week at 16OC regardless of the inoculum dose. Since the bacteria became systemic (i.e. were found in the blood), they were probably distributed to the different tissues via the circulation, and well-vascularised tissues such as the spleen had relatively higher recoveries on a weight:weight basis than less vascularised tissue such as the muscle. High recoveries were also found in the peritoneal cavity, presumably as a consequence of the injection route used.
That the metabolic deficiency resulting from the aroA deletion resulted in attenuation of Bnvax I1 was shown by the survival of the trout. Doses as high as 2 X log per fish had to be used before any mortalities were seen, similar to the situation using Brivax I in brown trout and Atlantic salmon where doses up to 10' bacteria per fish had no observable effects on fish health (Vaughan et al. 1990 ). The mortalities seen in the tion and antibody production in rainbow trout (Marsden et a1 1996a) Thus, a dose of 2 X 109 bacteria per fish would never be used in practice to vaccinate fish in aquaculture Interestingly, at this high dose differences in survival between individual fish were present as were differences in the speed of clearance froni tissues using lower doses Such differences may relate to genetic differences in the immune system, which is known to have polymorphic components (Bjering Jensen & Koch 1991, Wiegertles 1995) which can be selected to enhance disease resistance traits In aquaculture (Chevassus & Doison 1990 , Lund et a1 1995 The AaroA mutant is unable to synthesise chorismate, which in turn results in a block in folate biosynthesis. The latter deficiency is thought to be primarily responsible for the attenuation of aromatic-dependent bacteria (Hoiseth & Stocker 1981 , Vaughan et al. 1990 . Thus, such mutants would be expected to die after their folate reserves are exhausted, and this may result in the clearance observed. Nevertheless, in some tissues/fluids bacterial numbers increased over the first few days post-injection, as seen in the spleen, muscle and peritoneal fluid. Since muscle in particular represents a large total tissue mass, the overall number of bacteria in the fish will potentially increase during this period. This was confirmed using homogenates of whole fish, where following an initial and immediate decline in viability numbers rose over the next few days before being cleared. Similar results have been seen using virulent strains of A. salmonicida within a------p defences to klll the pathogen (Secombes & Ol~vier in press).
Both inoculum dose and temperature had a major impact on bacterial persistence. Whilst at first sight fast clearance may seem desirable, in fact this could limit the time available to stimulate a n effective immune response. Studies to examine this further are on-going but are complicated by the temperature sensitivity of the fish immune system (Bly & Clem 1992) . Thus, at low temperatures the increased bacterial persistence may give the immune system longer to be stimulated but the response may take longer to develop.
A 2 h crowding stress, which significantly elevated. serum glucose values to levels seen in other stress studies (Barton & Iwama 1991) and which is known from previous studies to result in suppression of several immune parameters (Thompson et al. 1993) , had no effect on clearance. This suggests that the AaroA attenuation is sufficient to allow clearance even in immunocompromised hosts, although clearly further studies are warranted to confirm thls.
In conclusion, the clearance data in this study combined with previous immunological studies (Marsden et al. 1996a, b) show that Rrivax I1 is attenuated and able to effectively stimulate the salmonid immune system. The relative degree of protection conferred on fish immunised with Brivax I1 versus fish immunised with killed vaccine preparations has still to be established, but such trials are clearly worthwhile. The use of Brivax I1 as a carrier of heterologous antigens also has potential for priming against other diseases (Marsden et al. 1996b ) and such studies are likely to extend to attenuated viral vaccines over the next few years.
